Levicept
Levicept develops biological agent for the treatment of chronic pain.
Levicept is a business in biopharma, biotechnology, medical device based in Europe, Middle East, and Africa (EMEA), founded in 2012.
The company sits in the biopharma, biotechnology, medical device segment, where it competes on its core product or service.
Its base of operations is Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Grant.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $12.4M.
| Sector | Biopharma, Biotechnology, Medical Device |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2012 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $12,400,000 |
Website: www.levicept.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account